SCHEMBL8577326

SCHEMBL8577326

O=C(N1CCNCC1)N1CCC[C@@H]1C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.47
CHKA P35790 1/20 0.47
CHRNB2 P17787 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42
CHRNB3 Q05901 1/20 0.42
CHRNA6 Q15825 1/20 0.42
NAMPT P43490 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
USP19 O94966 1/20 0.35
SCD5 Q86SK9 1/20 0.34
VNN1 O95497 1/20 0.34
RIPK1 Q13546 3/20 0.33
RET P07949 1/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD11B1 P28845 1/20 0.33
TACR1 P25103 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8575754 1.00 CA2 (0.47) CA2CHKACHRNB2CHRNA3CHRNA4
SCHEMBL18855618 0.86 ALDH1A1 (0.43) CA2CHKANAMPTUSP19RIPK1
SCHEMBL27889764 0.84 NAMPT (0.41) NAMPTUSP19SCD5VNN1RIPK1
SCHEMBL27873480 0.84 NAMPT (0.41) NAMPTUSP19SCD5VNN1RIPK1
SCHEMBL4780190 0.84 NAMPT (0.41) NAMPTUSP19SCD5VNN1RIPK1
SCHEMBL4772640 0.78 NAMPT (0.37) CA2NAMPTCA12CA1CA9
SCHEMBL8520605 0.76 CA2 (0.50) CA2CHKACHRNB2CHRNA3CHRNA4
SCHEMBL2830943 0.74 NAMPT (0.40) NAMPTSCD5VNN1RIPK1POLB
SCHEMBL18686787 0.73 SCD5 (0.40) NAMPTSCD5VNN1RIPK1POLB
SCHEMBL22468655 0.73 NAMPT (0.39) NAMPTSCD5VNN1RIPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012068450-A1 CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2012-05-24 WO disclosed